Profile overview
Who is Michael Cima?
Michael Cima is an inventor associated with United States. Their documented work in medical & dental includes TAR-200 intravesical drug-delivery system, the contribution at the center of this evidence-backed profile.
Michael Cima co-developed the implantable intravesical drug-delivery system that became TAR-200, a device that delivers chemotherapy locally in the bladder. MIT reports that the system began in Cima's lab, was co-developed through TARIS Biomedical and received FDA approval in 2025; MIT's current profile documents his implantable diagnostic and delivery-device research.
What did Michael Cima invent?
Co-developed the implantable intravesical drug-delivery system that became TAR-200 for bladder-cancer treatment.
What did Michael Cima accomplish?
TAR-200 turned a prolonged local drug-delivery concept into an FDA-approved device for an aggressive form of bladder cancer.
What is known about Michael Cima today?
MIT News reported in September 2025 on the FDA approval of technology conceived in Cima's lab, and MIT's current Koch Institute profile lists his active device research.
Comments
Write a comment